Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.88%
1,100.61
-9.73
-0.88%
—1,110.341,110.371,117.241,097.84——
SIXC
Communications
SIXC
Communications
SIXC
-1.33%
612.30
-8.24
-1.33%
—620.54620.54622.67611.42——
SIXE
Energy
SIXE
Energy
SIXE
+1.40%
1,175.46
+16.26
+1.40%
—1,159.201,160.591,177.621,156.21——
SIXI
Industrials
SIXI
Industrials
SIXI
-1.39%
1,729.12
-24.32
-1.39%
—1,753.441,749.081,762.011,724.74——
SIXM
Financials
SIXM
Financials
SIXM
-0.63%
644.73
-4.07
-0.63%
—648.80649.58655.73643.68——
SIXR
Staples
SIXR
Staples
SIXR
-0.65%
827.09
-5.40
-0.65%
—832.49832.07833.09826.15——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-1.98%
214.82
-4.34
-1.98%
—219.16219.16219.19214.82——
SIXT
Technology
SIXT
Technology
SIXT
+0.06%
3,115.17
+1.81
+0.06%
—3,113.363,120.793,143.643,105.16——
SIXU
Utilities
SIXU
Utilities
SIXU
-1.75%
910.43
-16.24
-1.75%
—926.67927.99930.54910.08——
SIXV
Health care
SIXV
Health care
SIXV
-1.01%
1,474.50
-15.11
-1.01%
—1,489.611,499.051,499.051,474.35——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.72%
2,405.87
-17.39
-0.72%
—2,423.262,438.162,443.462,399.83——
Q1 2026 earnings • released • EPS beat +6.45% • Revenue miss -0.77%
See results
DHR:NYSE
Danaher Corp
$194.54
-0.49%
(-0.96) 1D
$195.00
+0.24% (+0.46)
After hours
Closed: Apr 21, 4:00:06 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for DHR...
Open
$197.00
High
$200.50
Low
$190.46
Mkt. cap
137.68B
Avg. vol.
3.87M
Volume
7.86M
Dividend
0.82%
Quarterly dividend
$0.40
Ex dividend date
Mar 27, 2026
P/E ratio
38.70
52-wk high
$242.80
52-wk low
$180.03
EPS
$5.03
Beta
0.96
Shares outstanding
707.70M
No. of employees
59K
News stories
From sources across the web
Profile
Danaher Corporation is an American healthcare company headquartered in Washington, D.C.. It develops products used for advances in biotechnology, life sciences, and diagnostics. The company operates three divisions: biotechnology, which develops products for the development of therapeutics; life sciences, which develops products to identify causes of disease, new therapies, and to test and manufacture new drugs, vaccines and gene editing technologies; and diagnostics, which develops instruments, consumables, and software and services to diagnose diseases. Danaher was founded in 1984 by brothers Steven Rales and Mitchell Rales; it was named after Danaher Creek in Western Montana, where the brothers came up with the idea for the company while fishing. The company is ranked 180th on the Fortune 500 and 241st on the Forbes Global 2000. Wikipedia
About Danaher Corp
CEORainer M. Blair
Employees59K
Founded1969
Headquarters-
SectorHealth care
Websitedanaher.com
Last report
Just released
Today, 8:00 AM
Fiscal Period
Q1 2026
Normalized EPS / Estimate
2.06/ (1.94 est.)USD
+6.45%beat
Revenue / Estimate
5.95B/ (6.00B est.)USD
-0.77%miss
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
5.74B
5.94B
6.05B
6.84B
Cost of goods sold
2.22B
2.41B
2.53B
2.86B
Cost of revenue
2.22B
2.41B
2.53B
2.86B
Research and development expenses
379.00M
403.00M
378.00M
438.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.86B
1.93B
1.89B
2.03B
Operating expense
2.24B
2.33B
2.27B
2.46B
Total operating expenses
4.45B
4.74B
4.80B
5.32B
Operating income
1.29B
1.19B
1.26B
1.52B
Other non operating income
-
-
-
-87.00M
EBT including unusual items
1.13B
655.00M
1.08B
1.37B
EBT excluding unusual items
1.22B
1.13B
1.19B
1.39B
Income tax expense
175.00M
100.00M
168.00M
190.00M
Effective tax rate
15.50%
15.27%
15.61%
13.84%
Other operating expenses
-
-
-
-
Net income
954.00M
555.00M
908.00M
1.20B
Net profit margin
16.62%
9.35%
15.00%
17.51%
Earnings per share
1.88
1.80
1.89
2.23
Interest and investment income
6.00M
8.00M
3.00M
13.00M
Interest expense
-72.00M
-71.00M
-67.00M
-55.00M
Net interest expenses
-66.00M
-63.00M
-64.00M
-42.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
1.88B
1.80B
1.88B
2.14B
Gain or loss from assets sale
81.00M
-81.00M
-9.00M
9.00M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer